ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies

June 30, 2006

Nucynta ER Approved For Managing Chronic Pain In Adults

September 30, 2011

Spending Bill Could Give 15% Raise To NIH; Gimmicks Complicate Picture, Veto Looms

November 5, 1999

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978